YouTube Semaglutide Weight Loss Videos Show Variable Quality; Engagement Metrics Don't Predict Reliability
Background
The rapid rise in semaglutide use for weight loss has led to a surge of user-generated content on digital platforms like YouTube. This unchecked information environment often features non-evidence-based claims and patient experiences, creating a significant public health risk. Misinformation can lead to inappropriate self-medication, unrealistic expectations, or neglect of crucial safety information. Assessing the quality and reliability of this widely consumed content is vital to ensure individuals make informed health decisions regarding obesity and weight management.
Study Design
This cross-sectional study, conducted in December 2024, analyzed the 100 most-viewed English-language YouTube videos retrieved using the search term "semaglutide weight loss." Each video was independently assessed for quality and reliability using two validated tools: the Global Quality Score and the Modified DISCERN instrument. Viewer engagement data, including likes, comments, and views, were systematically recorded. Statistical analyses involved descriptive statistics and multiple linear regression to explore relationships between engagement metrics and the assessed content quality.
Results
Analysis of the 100 videos revealed significant variability in content quality. Videos from academic and healthcare-affiliated sources consistently scored higher in quality assessments. In contrast, content produced by individual users frequently lacked proper source citations and presented unbalanced information, often omitting critical details.
While certain engagement metrics, specifically the number of likes and comments, showed modest associations with higher
Global Quality Scores, the total view count did not consistently predict the reliability or quality of the content. A notable portion of user-generated videos failed to discuss essential information regarding semaglutide's risks, side effects, and contraindications, potentially misleading viewers about safe usage. This highlights a significant gap in comprehensive patient education within popular digital health content.
Key Findings
- Academic and healthcare-affiliated YouTube videos on semaglutide scored higher in quality.
- User-generated videos often lacked source citations and balanced information.
- View count did not consistently predict the quality or reliability of semaglutide content.
- Many user-generated videos omitted discussions of semaglutide's risks and contraindications.
- Likes and comments showed modest associations with higher video quality scores.
Why It Matters
This study underscores a critical need for enhanced digital health literacy among individuals seeking information on semaglutide for weight loss. Viewers should prioritize content from academic or healthcare-affiliated sources and exercise caution with popular user-generated videos, as high engagement does not equate to reliability. Clinicians and public health initiatives must actively guide patients toward credible, evidence-based resources to counter misinformation. This finding is crucial for anyone considering or currently using semaglutide, as it directly impacts their ability to access accurate dosing, safety, and efficacy information, potentially influencing adherence and outcomes.
semaglutide
weight loss
youtube
health information
misinformation
digital health literacy